These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19286635)

  • 1. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.
    Wang X; Dong J; Zhao Y; Li Y; Wu M
    Lipids Health Dis; 2011 Jan; 10():7. PubMed ID: 21235823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
    Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
    J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.
    Fan Y; Shi F; Liu J; Dong J; Bui HH; Peake DA; Kuo MS; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2114-20. PubMed ID: 20814016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice].
    Qin R; Chen ML; Zhu K; Deng JB; Shi YY
    Sheng Li Xue Bao; 2010 Aug; 62(4):333-8. PubMed ID: 20717634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
    Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
    Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
    Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
    Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
    J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
    Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
    Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
    J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Total SMS Activity on LDL Catabolism in Mice.
    Li Z; He M; Chen G; Souaiaia T; Worgall TS; Jiang XC
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1251-1261. PubMed ID: 37128925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
    Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
    J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
    Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
    J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
    Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
    Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation.
    Hailemariam TK; Huan C; Liu J; Li Z; Roman C; Kalbfeisch M; Bui HH; Peake DA; Kuo MS; Cao G; Wadgaonkar R; Jiang XC
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1519-26. PubMed ID: 18566297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingomyelin synthase 2 over-expression induces expression of aortic inflammatory biomarkers and decreases circulating EPCs in ApoE KO mice.
    Zhao YR; Dong JB; Li Y; Wu MP
    Life Sci; 2012 Jun; 90(21-22):867-73. PubMed ID: 22538014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
    Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
    Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
    Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
    Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.